00932nas a2200325   4500000000100000008004100001260001700042653002900059653002900088653001200117653001800129653003200147653001100179653001200190653001900202653002300221653002500244100001400269700001800283700001500301700001800316700001400334700001800348700001500366700001600381245017700397300001100574490000700585022001400592       1967                            d  c1967 Apr-Jun10aAnti-Inflammatory Agents10aClinical Trials as Topic10aDapsone10aDexamethasone10aEvaluation Studies as Topic10aHumans10aleprosy10aMefenamic Acid10aMethandrostenolone10aortho-Aminobenzoates1 aDOULL J A1 aTolentino J G1 aGuinto R S1 aRodriguez J N1 aLeano L M1 aFERNANDEZ J V1 aRIVERA J N1 aFajardo T T00aClinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.  a128-390 v35  a0148-916X